Novartis Plans New $15 Bln Share Buyback To Be Executed By 2023-end
16/12 07:22
(RTTNews) - Swiss drug maker Novartis (NVS) announced Thursday that it will initiate a share buyback of up to $15 billion to be executed by the end of 2023, highlighting confidence in top line growth and deep pipeline....